The findings that GATA3 stimulates DSB repair through HR and reconstitution of Gata3 restores the HR efficiency of Brca1-deficient cancer cells prompting us to investigate the response of Gata3-deficient tumor cells to PARP inhibitor. Here, GATA3 is linked to neoplasm.